1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
Read TARCC's Latest Facebook Posts:
TARCC investigator, Bharti Manwani at UT Health Houston, examines the influence of gender on build-up of proteins in brain blood vessels, a major contributor to impaired cognition and stroke. www.sciencedirect.com/science/article/pii/S2666354621000636
Contributing to an important national genetics consortium study, TARCC samples were used to examine the involvement of mitochondrial dysfunction in AD-related brain pathology.alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12396
TARCC investigator Dr. Gladys Maestre will testify in an open hearing for the U.S. House of Representatives addressing the global health care gaps in terms of Alzheimer’s disease diagnosis and treatment. Livestream the hearing at 9am CST on Friday June 25th. Click link here: foreignaffairs.house.gov/2021/6/brain-health-a-global-perspective